The Readout Loud cover image

265: Novavax's CEO promises a turnaround & how Lilly roiled the obesity market

The Readout Loud

00:00

Pfizer's Discontinuation of Trials of Small Molecule Pills

Pfizer's process is apparently getting a little more complicated in this field than maybe was initially thought. Some people see it as kind of setting back Pfizer in this race to develop oral products for obesity. So it seems like especially compared with Lillie Pfizer is falling behind and Lillie is really emerging as getting ahead in, especially in the race to developed oral products.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app